Dietary fiber and microbiota metabolite receptors enhance cognition and alleviate disease in the 5xFAD mouse model of Alzheimer’s disease

Yichen Zhou, Liang Xie, Jan Schröder, Iona S. Schuster, Michael Nakai, Guizhi Sun, Yu B.Y. Sun, Eliana Mariño, Mariapia A. Degli-Esposti, Francine Z. Marques, Alexandra Grubman, Jose M. Polo, Charles R. Mackay

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder with poorly understood aetiology. AD has several similarities with other ‘Western lifestyle’ inflammatory diseases, where the gut microbiome and immune pathways have been associated. Previously, we and others have noted the involvement of metabolite-sensing G protein coupled receptors (GPCRs) and their ligands, short-chain fatty acids (SCFAs), in protection of numerous Western diseases in mouse models, such as type I diabetes, hypertension. Depletion of GPR43, GPR41 or GPR109A accelerates disease, whereas high SCFA yielding diets protect in mouse models. Here, we extended the concept that metabolite-sensing receptors and SCFAs may be a more common protective mechanism against Western diseases by studying their role in AD pathogenesis in the 5xFAD mouse model. Both male and female mice were included. Depletion of GPR41 and GPR43 accelerated cognitive decline and impaired adult hippocampal neurogenesis (AHN) in 5xFAD and WT mice. Lack of fiber/SCFAs accelerated a memory deficit, whereas diets supplemented with high acetate and butyrate (HAMSAB) delayed cognitive decline in 5xFAD mice. Fiber intake impacted on microglial morphology in WT mice and microglial clustering phenotype in 5xFAD mice. Lack of fiber impaired AHN in both W and AD mice. Finally, maternal dietary fiber intake significantly affects offspring’s cognitive functions in 5xFAD mice and microglial transcriptome in both WT and 5xFAD mice, suggesting that SCFAs may exert their effect during pregnancy and lactation. Altogether, metabolite-sensing GPCRs and SCFAs are essential for protection against AD, and reveal a new strategy for disease prevention.

Original languageEnglish
Pages (from-to)6460-6475
Number of pages59
JournalThe Journal of Neuroscience
Volume43
Issue number37
DOIs
Publication statusPublished - 13 Sept 2023

Cite this